Home › Multiple Myeloma › Montana
Multiple Myeloma clinical trials in Montana
5 studies for Multiple Myeloma are looking for participants at sites in Montana.
Cities in Montana
Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Benefis Sletten Cancer Institute, Great Falls
- and 2 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06948084Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- Saint Patrick Hospital - Community Hospital, Missoula
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT04566328Integrated Cancer Repository for Cancer Research
- Bozeman Health Deaconess Hospital, Bozeman
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- Saint Patrick Hospital - Community Hospital, Missoula
RecruitingPhase 3
All ages · All sexes · Updated Jun 10, 2026 · NCT05561387A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
- GSK Investigational Site, Billings
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Apr 22, 2026 · NCT06679101From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.